Last reviewed · How we verify

NCT03377751

Does VoltagE Guided Additional Ablation Improve Procedural Outcome of Atrial Fibrillation Ablation?

Terminated NA Last updated 9 September 2020
What this trial tests

NA trial testing Additional posterior wall isolation in Atrial Fibrillation in 20 participants. Terminated before completion.

Timeline
15 February 2018
Primary endpoint
15 December 2019
15 December 2019

Quick facts

Lead sponsorKorea University Guro Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date15 February 2018
Primary completion15 December 2019
Estimated completion15 December 2019
Sites3 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Korea University Guro Hospital

Who can join

19 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to investigate whether pulmonary vein isolation(PVI) plus stepwise additional ablation approach based on the degree of low voltage area versus PVI only can improve procedure outcome in persistent atrial fibrillation(AF) patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Korea University Guro Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03377751.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing